F/M Investments’s Edwards Lifesciences EW Stock Holding History

F/M Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-81,711	Closed	-$7.55M	–	346
2024 Q2	$7.55M	Buy	+81,711	New	+$7.24M	0.27%	125

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

F/M Investments's EW Position: Q3 2024 in Review

F/M Investments sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 81,711 shares — an estimated $7.55M sold.

F/M Investments first reported a position in EW in Q2 2024 and held it in 1 quarter. The position peaked at $7.55M in Q2 2024. 1,193 funds tracked by Wall St. Rank hold EW as of Q3 2024.

F/M Investments reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
F/M Investments sold 81,711 Edwards Lifesciences shares in Q3 2024, an estimated $7.55M.
F/M Investments first reported a position in Edwards Lifesciences in Q2 2024 and held it in 1 quarter.
F/M Investments's Edwards Lifesciences position peaked at $7.55M in Q2 2024.
1,193 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on F/M Investments's 13F filing for Q3 2024, filed 29 Oct 2024.